Clinical Extend Study to Evaluate Safety and Effectiveness of TnR Nasal Mesh for Correction of Nasal Septum on Patients

Nasal Obstruction Clinical Trial

Official title:

Clinical Extend Study to Evaluate Safety and Effectiveness of TnR Nasal Mesh for Correction of Nasal Septum on Patients Who Need Correction of Nasal Septum That Accompanies With Rhinanchone Symptom

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04332575
• Other study ID #: TRBF-002
• Status: Not yet recruiting
• Start date: April 2020
• Est. completion date: November 2020

Study information

• Verified date: April 2020
• Source: T&R Biofab Co., Ltd.
• Contact: Jeongmin Choi, pm
• Phone: 02-2258-7896
• Email: Jeongmin.choi[@]mediex.co.kr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this observation study is to evaluate long term safety and efficacy at 2~3 years after surgery on patients who have completed nasal septal deformity surgery using TnR Nasal Mesh.

Description:

Nasal obstruction is a nasal disease commonly seen in the area of otolaryngology, and major symptoms include nasal congestion, rhinitis, and etc.

Nasal septoplasty is a surgery performed to improve above symptoms of nasal obstruction and so far, many surgical technique have been studied. All surgical techniques aimed to improve breathing through the nasal cavity by supporting the end of nose using surgical materials such as autologous bone or nonabsorbable material.

In the case of autologous bone transplantation, safety is ensured, but there is a limitation since it causes deficiency of the donor site, and the nasal septum may be altered by a modification of the implanted tissue.

In the case of nonabsorbable materials, there is a high risk of side effects such as hyposmia, septal perforation, and occurrence of boil.

TnR Nasal Mesh, as a surgical material for nasal septoplasty has a sufficient flexural strength to support the nasal septum and to overcome the force of returning to a deviated state prior to surgery.

Animal tests have shown that TnR Nasal mesh well supports the nasal septum after surgery and the surrounding tissue is well fused between the pores without inflammatory responses. Based on above results, a clinical trial was planned to evaluate long term safety and efficacy of TnR Nasal Mesh as a material for nasal septoplasty.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 20
• Est. completion date: November 2020
• Est. primary completion date: April 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 19 Years to 74 Years

Eligibility

Inclusion Criteria:

1. Patients who have completed nasal septal deformity surgery using TnR Nasal Mesh.

2. Females of childbearing potential must have a negative urine pregnancy test, and must not plan to become pregnant during the course of the study.

3. A person who voluntarily signed a consent form after hearing and understanding the description of this clinical study.

Exclusion Criteria:

1. Pregnancy or lactation

• Before screening

2. History of surgery in nasal or paranasal sinuses before screening

3. History of radiation treatment at Head and neck

4. History of having participated in other clinical trial of a drug/ a medical device within three months

• Screening point

5. Patients with untreated nasal bone fraction or trauma of nasal

6. Patients with surgical site infection caused by nasal bone fraction or trauma

7. Patients with inflammation in a nasal cavity

8. Patients with asthma

9. Patients with untreated a perforation of septum, a sinusitis, a nasal cavity polyposis, a nasal cavity sarcoidosis, nasal valve collapse or wegener's granulomatosis

10. Patients with sarcoma or carcinoma in a nasal cavity

11. Patients with untreated palate-facial disfigurements or cleft palate

12. Patients with sepsis

13. Patients with systemic inflammatory disease

14. Patients who are unsuitable for clinical sturdy determined by the researcher.

Related Conditions & MeSH terms

• Congenital Abnormalities
• Nasal Obstruction
• Septal Deformity

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
T&R Biofab Co., Ltd.

References & Publications (9)

Boenisch M, Nolst Trenité GJ. Reconstruction of the nasal septum using polydioxanone plate. Arch Facial Plast Surg. 2010 Jan-Feb;12(1):4-10. doi: 10.1001/archfacial.2009.103. — View Citation

Erickson B, Hurowitz R, Jeffery C, Ansari K, El Hakim H, Wright ED, Seikaly H, Greig SR, Côté DW. Acoustic rhinometry and video endoscopic scoring to evaluate postoperative outcomes in endonasal spreader graft surgery with septoplasty and turbinoplasty for nasal valve collapse. J Otolaryngol Head Neck Surg. 2016 Jan 12;45:2. doi: 10.1186/s40463-016-0115-9. — View Citation

Garcia LB, Oliveira PW, Vidigal Tde A, Suguri Vde M, Santos Rde P, Gregório LC. Caudal septoplasty: efficacy of a surgical technique-preliminary report. Braz J Otorhinolaryngol. 2011 Mar-Apr;77(2):178-84. English, Portuguese. — View Citation

Kahveci OK, Miman MC, Yucel A, Yucedag F, Okur E, Altuntas A. The efficiency of Nose Obstruction Symptom Evaluation (NOSE) scale on patients with nasal septal deviation. Auris Nasus Larynx. 2012 Jun;39(3):275-9. doi: 10.1016/j.anl.2011.08.006. Epub 2011 Aug 31. — View Citation

Kim JH, Kim DY, Jang YJ. Outcomes after endonasal septoplasty using caudal septal batten grafting. Am J Rhinol Allergy. 2011 Jul-Aug;25(4):e166-70. doi: 10.2500/ajra.2011.25.3648. — View Citation

Kim JN, Choi HG, Kim SH, Park HJ, Shin DH, Jo DI, Kim CK, Uhm KI. The efficacy of bioabsorbable mesh as an internal splint in primary septoplasty. Arch Plast Surg. 2012 Sep;39(5):561-4. doi: 10.5999/aps.2012.39.5.561. Epub 2012 Sep 12. — View Citation

Rimmer J, Ferguson LM, Saleh HA. Versatile applications of the polydioxanone plate in rhinoplasty and septal surgery. Arch Facial Plast Surg. 2012 Sep-Oct;14(5):323-30. doi: 10.1001/archfacial.2012.147. — View Citation

Stewart MG, Smith TL, Weaver EM, Witsell DL, Yueh B, Hannley MT, Johnson JT. Outcomes after nasal septoplasty: results from the Nasal Obstruction Septoplasty Effectiveness (NOSE) study. Otolaryngol Head Neck Surg. 2004 Mar;130(3):283-90. — View Citation

Surowitz J, Lee MK, Most SP. Anterior Septal Reconstruction for Treatment of Severe Caudal Septal Deviation: Clinical Severity and Outcomes. Otolaryngol Head Neck Surg. 2015 Jul;153(1):27-33. doi: 10.1177/0194599815582176. Epub 2015 Apr 16. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Total NOSE score change after surgery compared to before surgery	The descriptive statistics(population, mean, standard deviation, median, minimum, maximun value) are presented for total NOSE score change after surgery compared to before surgery.; All measurement will be completed at the time of each patient's initial visit, 1 day; Total NOSE score of before surgery is based on the results of previous clinical study.; The NOSE(Nasal Obstruction Symptom Evaluation) score is a 5-step scale (0(asymptomatic)-4(very severe) points) of the severity of each symptom over the past month for the 5 symptoms related to nasal obstruction (nasal hyperemia / snagging / difficulty in breathing / sleeping disorder / difficulty breathing during exercise). Then, it is evaluated by interviewing patient. The total score of 20 points is converted to 100 points and recorded.	1 day
Secondary	NOSE score change	NOSE score change for each item after surgery compared to before.; All measurement will be completed at the time of each patient's initial visit, 1 day; The NOSE(Nasal Obstruction Symptom Evaluation) score is a 5-step scale (0(asymptomatic)-4(very severe) points) of the severity of each symptom over the past month for the 5 symptoms related to nasal obstruction (nasal hyperemia / snagging / difficulty in breathing / sleeping disorder / difficulty breathing during exercise). Then, it is evaluated by interviewing the patient. The total score of 20 points is converted to 100 points and recorded.	1 day
Secondary	Acoustic rhinometry results(volume)	Changes after surgery compared to before surgery on bilateral nasal cavity volume in acoustic rhinometry result.; All measurement will be completed at the time of each patient's initial visit, 1 day	1 day
Secondary	Acoustic rhinometry results(cross sectional area)	Changes after surgery compared to before surgery on bilateral nasal cavity cross sectional area in acoustic rhinometry result.; All measurement will be completed at the time of each patient's initial visit, 1 day	1 day
Secondary	CT images(cross sectional area)	Changes after surgery compared to before surgery on bilateral nasal cavity cross sectional area in CT images.; All measurement will be completed at the time of each patient's initial visit, 1 day	1 day
Secondary	CT images(ratio of convex to concave side)	Changes after surgery compared to before surgery on nasal cavity ratio of convex to concave side of cross-sectional area in CT images.; All measurement will be completed at the time of each patient's initial visit, 1 day	1 day
Secondary	CT images(nasal septum angle)	Changes after surgery compared to before surgery on nasal septum angle in CT images.; All measurement will be completed at the time of each patient's initial visit, 1 day	1 day
Secondary	Ratio of improvement of regarding symptoms after surgery	Symptom improvement is defined as the total NOSE score reduced by more than 40 points compared to before surgery or the total NOSE score less than 20 points after surgery.; All measurement will be completed at the time of each patient's initial visit, 1 day; The NOSE(Nasal Obstruction Symptom Evaluation) score is a 5-step scale (0(asymptomatic)-4(very severe) points) of the severity of each symptom over the past month for the 5 symptoms related to nasal obstruction (nasal hyperemia / snagging / difficulty in breathing / sleeping disorder / difficulty breathing during exercise). Then, it is evaluated by interviewing the patient. The total score of 20 points is converted to 100 points and recorded.	1 day
Secondary	Level of satisfaction of patients using VAS	The patient satisfaction is evaluated using VAS(Visual Analogue Scale).; All measurement will be completed at the time of each patient's initial visit, 1 day; VAS(Visual Analogue Scles)Scoring and Interpretation Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.	1 day

External Links

•   Description SIDS Initial Assessment Report